Evaluation of venous thromboembolism risk assessment models for hospital inpatients: the VTEAM evidence synthesis
Bewertung von Risikobewertungsmodellen für venöse Thromboembolien bei stationären Patient:innen: die VTEAM-Evidenzsynthese
Health Technology Assessment · 2024-04 · 1-166
DOI: 10.3310/awtw6200 ↗Auf einen Blick
Die Evidenzsynthese fand 24 validierte Risikobewertungsmodelle. Die Daten sprechen für eine schwache Vorhersage von Blutgerinnseln und dafür, dass Thromboprophylaxe für alle meist kosteneffektiver ist als modellbasierte Strategien.
Fragestellung
Wie genau sind Risikobewertungsmodelle für venöse Thromboembolien bei stationären Patient:innen, und wie kosteneffektiv sind prophylaktische Strategien im Vergleich?
Methode
Systematische Übersichtsarbeit, entscheidungsanalytische Modellierung und Beobachtungs-Kohortenstudie in NHS-Krankenhäusern; Patient:innen mit medizinischen und chirurgischen Aufnahmen, ohne pädiatrische, Intensiv- und schwangerschaftsbezogene Aufnahmen.
Ergebnisse
24 validierte Modelle; die heterogenen, niedrig qualitativen Daten zeigten eine schwache Vorhersage von Blutgerinnseln und ein insgesamt hohes Verzerrungsrisiko. Prophylaxe für alle war bei £20.000 pro QALY meist kosteneffektiver als modellbasierte Strategien.
Einschränkungen
Mögliche Unterschätzung der Modellgenauigkeit; keine Gültigkeit für Patient:innen mit erhöhtem Blutungsrisiko; mechanische Prophylaxe ausgeschlossen; Datenerhebung überwiegend retrospektiv.
Schlussfolgerung der Autor:innen
Thromboprophylaxe für alle Patient:innen erscheint bei hospitalisierten Patient:innen mit niedrigem Blutungsrisiko meist kosteneffektiver als die Nutzung eines Risikomodells. Ein Modell müsste sehr sensitiv sein, um kosteneffektiv zu sein.
Kernaussagen
- 24 validierte Risikomodelle wurden identifiziert
- Vorhersage von Blutgerinnseln insgesamt schwach
- Thromboprophylaxe für alle meist kosteneffektiver als modellbasiert
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Systematische Übersicht in der Zeitschrift Health Technology Assessment, 2024-04. Verfasst von Daniel Edward Horner und 14 weiteren Autor:innen. Beteiligte Einrichtung: Emergency Department, Northern Care Alliance NHS Foundation Trust, Salford, UK. Hauptthemen laut MEDLINE: Venous Thromboembolism, Cost-Benefit Analysis, Anticoagulants, Quality-Adjusted Life Years. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 174 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Technology Assessment programme.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Background
Pharmacological prophylaxis during hospital admission can reduce the risk of acquired blood clots (venous thromboembolism) but may cause complications, such as bleeding. Using a risk assessment model to predict the risk of blood clots could facilitate selection of patients for prophylaxis and optimise the balance of benefits, risks and costs.
Objectives
We aimed to identify validated risk assessment models and estimate their prognostic accuracy, evaluate the cost-effectiveness of different strategies for selecting hospitalised patients for prophylaxis, assess the feasibility of using efficient research methods and estimate key parameters for future research.
Design
We undertook a systematic review, decision-analytic modelling and observational cohort study conducted in accordance with Enhancing the QUAlity and Transparency Of health Research (EQUATOR) guidelines.
Setting
NHS hospitals, with primary data collection at four sites.
Participants
Medical and surgical hospital inpatients, excluding paediatric, critical care and pregnancy-related admissions.
Interventions
Prophylaxis for all patients, none and according to selected risk assessment models. Main outcome measures Model accuracy for predicting blood clots, lifetime costs and quality-adjusted life-years associated with alternative strategies, accuracy of efficient methods for identifying key outcomes and proportion of inpatients recommended prophylaxis using different models.
Results
We identified 24 validated risk assessment models, but low-quality heterogeneous data suggested weak accuracy for prediction of blood clots and generally high risk of bias in all studies. Decision-analytic modelling showed that pharmacological prophylaxis for all eligible is generally more cost-effective than model-based strategies for both medical and surgical inpatients, when valuing a quality-adjusted life-year at £20,000. The findings were more sensitive to uncertainties in the surgical population; strategies using risk assessment models were more cost-effective if the model was assumed to have a very high sensitivity, or the long-term risks of post-thrombotic complications were lower. Efficient methods using routine data did not accurately identify blood clots or bleeding events and several pre-specified feasibility criteria were not met. Theoretical prophylaxis rates across an inpatient cohort based on existing risk assessment models ranged from 13% to 91%.
Limitations
Existing studies may underestimate the accuracy of risk assessment models, leading to underestimation of their cost-effectiveness. The cost-effectiveness findings do not apply to patients with an increased risk of bleeding. Mechanical thromboprophylaxis options were excluded from the modelling. Primary data collection was predominately retrospective, risking case ascertainment bias.
Conclusions
Thromboprophylaxis for all patients appears to be generally more cost-effective than using a risk assessment model, in hospitalised patients at low risk of bleeding. To be cost-effective, any risk assessment model would need to be highly sensitive. Current evidence on risk assessment models is at high risk of bias and our findings should be interpreted in this context. We were unable to demonstrate the feasibility of using efficient methods to accurately detect relevant outcomes for future research. Future work Further research should evaluate routine prophylaxis strategies for all eligible hospitalised patients. Models that could accurately identify individuals at very low risk of blood clots (who could discontinue prophylaxis) warrant further evaluation. Study registration This study is registered as PROSPERO CRD42020165778 and Researchregistry5216. Funding This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: NIHR127454) and will be published in full in Health Technology Assessment ; Vol. 28, No. 20. See the NIHR Funding and Awards website for further award information.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Emergency Department, Northern Care Alliance NHS Foundation Trust, Salford, UK.
- Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Oxford Road, Manchester, UK.
- School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.
- Barts Bone and Joint Health, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
- School of Clinical and Biomedical Sciences, Faculty of Health and Wellbeing, University of Bolton, Bolton, UK.
- Thrombosis & Haemophilia Centre, St Thomas' Hospital, King's Healthcare Partners, London, UK.
ORCID-Profile: Daniel Edward Horner, Sarah Davis, Abdullah Pandor, Helen Shulver, Steve Goodacre, Daniel Hind, Saleema Rex, Michael Gillett, Matthew Bursnall, Xavier Griffin, Mark Holland, Beverley Jane Hunt, Kerstin de Wit
Förderung
- Health Technology Assessment programme
Zitieren
APA
Horner, D. E., Davis, S., Pandor, A., Shulver, H., Goodacre, S., Hind, D., Rex, S., Gillett, M., Bursnall, M., Griffin, X., Holland, M., Hunt, B. J., de Wit, K., Bennett, S., & Pierce-Williams, R. (2024). Evaluation of venous thromboembolism risk assessment models for hospital inpatients: the VTEAM evidence synthesis. Health Technology Assessment, 1-166. https://doi.org/10.3310/awtw6200
Vancouver
Horner DE, Davis S, Pandor A, Shulver H, Goodacre S, Hind D, et al. Evaluation of venous thromboembolism risk assessment models for hospital inpatients: the VTEAM evidence synthesis. Health Technology Assessment. 2024:1-166. doi:10.3310/awtw6200
BibTeX
@article{Horner2024,
author = {Horner, Daniel Edward and Davis, Sarah and Pandor, Abdullah and Shulver, Helen and Goodacre, Steve and Hind, Daniel and Rex, Saleema and Gillett, Michael and Bursnall, Matthew and Griffin, Xavier and Holland, Mark and Hunt, Beverley Jane and de Wit, Kerstin and Bennett, Shan and Pierce-Williams, Robin},
title = {Evaluation of venous thromboembolism risk assessment models for hospital inpatients: the VTEAM evidence synthesis},
journal = {Health Technology Assessment},
year = {2024},
pages = {1--166},
doi = {10.3310/awtw6200}
}
EUVIMED